Lipid-Lowering Drugs Associated With Lower Risk of Retinopathy and Ophthalmic Interventions in Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Lipid-Lowering Medications Are Associated With Lower Risk of Retinopathy and Ophthalmic Interventions Among U.S. Patients With Diabetes
Am J Ophthalmol 2019 Jun 10;[EPub Ahead of Print], D Vail, NF Callaway, CA Ludwig, N Saroj, DM MoshfeghiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.